Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9H7G

Human Transthyretin in Complex with 1H-indole-3-carbonitrile

Summary for 9H7G
Entry DOI10.2210/pdb9h7g/pdb
DescriptorTransthyretin, CALCIUM ION, 1~{H}-indole-3-carbonitrile, ... (4 entities in total)
Functional Keywordsamyloidosis, retinol, thyroxine, rbp, transport protein
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight27919.19
Authors
Chen, W. (deposition date: 2024-10-27, release date: 2025-03-12, Last modification date: 2025-05-28)
Primary citationChen, W.
Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method.
Plos One, 20:e0323816-e0323816, 2025
Cited by
PubMed Abstract: A Capillary Zone Electrophoresis (CZE) fragment screening methodology was developed and applied to the human plasma protein Transthyretin (TTR), normally soluble, but could misfold and aggregate, causing amyloidosis. Termed Free Probe Peak Height Restoration (FPPHR), it monitors changes in the level of free ligand known to bind TTR (the Probe Ligand) in the presence of competing fragments. 129 fragments were screened, 12 of the 16 initial hits (12.4% hit rate) were co-crystallised with TTR, 11 were found at the binding site (92% confirmation rate). Subsequent analogue screens have identified a novel TTR-binding scaffold 4-(3H-pyrazol-4-yl)quinoline and its derived compounds were further studied by crystallography, circular dichroism (CD), isothermal titration calorimetry (ITC) and radiolabelled 125I-Thyroxine displacement assay in neat plasma. Two lead molecules had similar ITC Kd and 125I-Thyroxine displacement IC50 values to that of Tafamidis, adding another potential pipeline for transthyretin amyloidosis. The methodology is reproducible, procedurally simple, automatable, label-free without target immobilisation, non-fluorescence based and site-specific with low false positive rate, which could be applicable to fragment screening of many drug targets.
PubMed: 40367241
DOI: 10.1371/journal.pone.0323816
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.49 Å)
Structure validation

236620

數據於2025-05-28公開中

PDB statisticsPDBj update infoContact PDBjnumon